Buy RLAY by Sep 28, 2026.

This stock keeps climbing.. The combination of a Phase 3 breast cancer trial underway, a potential accelerated approval path in vascular anomalies, FDA Breakthrough status, and two years of cash is a pretty compelling setup for a clinical-stage biotech. Every day or every few days it has a 5% run. Anybody have opinions on these guys? Cambridge MA is the world capitol for bio tech right now and these guys are right in the thick kf it